Healthcare · NIFTY 500

Krishna Institute of Medical Sciences Limited

NSEKIMS BSE543308 ISININE967H01025 SeriesEQ Listed on NSE · BSE · MSEI

₹726.00 -0.15 (-0.02%) Updated 12 Nov, 8:49 pm IST

Open chart Back to screener

Price, daily close+0.86% in a year

Today

Open: ₹726.15
Prev close: ₹726.15
Day high: ₹730.35
Day low: ₹717.05
Volume: 5.40 L
Value traded: ₹38.99 Cr
Upper circuit: ₹871.35
Lower circuit: ₹580.95
52W high: ₹858.00
52W low: ₹575.80
1 month: +5.22%
6 months: -7.05%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹30,492 Cr

P/E (TTM)139.08

P/B7.76

Book value / share₹93.61

EPS (TTM)₹5.22

ROE5.4%

Dividend yield—

Dividend (12m)—

Net margin (TTM)4.6%

Operating margin20.3%

Debt / equity0.90

Current ratio1.11

EV / EBITDA38.12

Sales growth (YoY qtr)+39.94%

Profit growth (YoY qtr)+11.77%

Sales CAGR 3Y+21.12%

Profit CAGR 3Y-10.46%

Shares42.00 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

60671.8

Dec 23

63465.5

Mar 24

68886.6

Jun 24

777107

Sep 24

77292.5

Dec 24

797102

Mar 25

87278.6

Jun 25

96167.1

Sep 25

99853.4

Dec 25

1,07542.5

Mar 26

1,18041.5

Jun 26

1,34475.0

Sep 26

Revenue · QoQ (vs last quarter)

—+4.6%+8.6%+13%-0.6%+3.2%+9.4%+10%+3.9%+7.7%+9.8%+14%

Revenue · YoY (vs a year ago)

————+27%+26%+27%+24%+29%+35%+35%+40%

Net profit · QoQ (vs last quarter)

—-8.9%+32%+24%-14%+10%-23%-15%-20%-20%-2.4%+81%

Net profit · YoY (vs a year ago)

————+29%+55%-9.2%-38%-42%-58%-47%+12%

RevenueNet profitLine = trend

8.98

Dec 23

8.18

Mar 24

10.82

Jun 24

2.68

Sep 24

2.22

Dec 24

2.54

Mar 25

1.96

Jun 25

1.67

Sep 25

1.33

Dec 25

1.06

Mar 26

1.04

Jun 26

1.79

Sep 26

EPS (₹) · YoY (vs a year ago)

————-75%-69%-82%-38%-40%-58%-47%+7.2%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	606	634	688	777	772	797	872	961	998	1,075	1,180	1,344
Other income	3.3	3.8	4.6	5.0	17.8	4.5	7.1	4.2	5.2	9.7	16.4	18.6
Total income	609	638	693	782	790	801	879	965	1,003	1,084	1,196	1,363
Raw material	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Purchases	124	135	145	157	170	169	192	204	211	235	261	284
Employee cost	104	109	119	119	128	134	151	175	176	180	213	232
Other expenses	229	232	248	285	296	298	344	387	426	455	499	575
Total expenses	507	537	566	620	656	678	765	868	934	1,021	1,140	1,270
Operating profit	147	159	179	218	187	209	193	204	199	196	223	274
OPM %	24.3%	25.1%	26.1%	28.1%	24.2%	26.2%	22.1%	21.2%	19.9%	18.2%	18.9%	20.3%
Finance cost	12.4	16.4	17.9	19.9	25.7	26.7	32.6	45.0	56.8	68.1	83.4	65.5
Depreciation	35.4	46.3	39.0	41.0	44.7	52.6	53.4	66.1	78.7	85.0	101	121
Exceptional items	—	—	—	—	—	10.8	—	-0.3	—	-10.9	—	13.2
Profit before tax	103	100	127	162	135	134	114	96.8	68.6	52.2	55.6	106
Tax	25.9	28.5	31.9	41.5	42.1	27.9	28.7	24.8	16.7	21.7	19.2	30.9
Net profit	76.6	71.5	95.2	121	92.5	106	85.0	72.0	51.9	33.1	37.4	74.6
Profit to shareholders	71.8	65.5	86.6	107	—	102	78.6	67.1	53.4	42.5	41.5	75.0
EPS (₹)	8.98	8.18	10.82	2.68	2.22	2.54	1.96	1.67	1.33	1.06	1.04	1.79

Profit & loss

Results for each year

6 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

1,330371201

FY21

1,651516333

FY22

2,198619336

FY23

2,498640310

FY24

3,035794385

FY25

3,905791241

FY26

Revenue · YoY (vs a year ago)

—+24%+33%+14%+21%+29%

Net profit · YoY (vs a year ago)

—+65%+1.1%-7.8%+24%-37%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	1,330	1,651	2,198	2,498	3,035	3,905
Other income	10.2	20.3	25.9	13.1	31.9	26.2
Total expenses	1,061	1,224	1,753	2,051	2,520	3,588
Employee cost	220	262	346	422	500	682
Operating profit	371	516	619	640	794	791
OPM %	27.9%	31.2%	28.2%	25.6%	26.2%	20.3%
Finance cost	32.5	16.0	30.5	47.0	90.3	203
Depreciation	69.5	72.7	129	147	177	283
Profit before tax	279	447	485	460	558	331
Tax	73.5	114	119	124	143	91.9
Tax rate %	26.4%	25.6%	24.6%	26.9%	25.7%	27.7%
Net profit	205	344	366	336	415	242
Profit to shareholders	201	333	336	310	385	241
Net margin %	15.1%	20.2%	15.3%	12.4%	12.7%	6.2%
EPS (₹)	26.20	41.88	42.03	38.75	9.61	6.03

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

1,67067861.6

Mar 23

1,8281,35546.9

Mar 24

2,1382,55756.0

Mar 25

2,2473,24455.4

Mar 26

3,9323,53852.8

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+9.5%+17%+5.1%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	1,670	1,828	2,138	2,247	3,932
Long-term borrowings	634	1,226	2,287	2,673	2,914
Short-term borrowings	44.6	129	270	571	624
Total borrowings	678	1,355	2,557	3,244	3,538
Current liabilities	296	452	836	1,239	1,413
Fixed assets (PPE)	1,381	1,730	2,199	4,186	4,798
Inventories	42.9	49.4	64.0	96.9	119
Trade receivables	253	294	395	554	691
Cash & equivalents	61.6	46.9	56.0	55.4	52.8
Current assets	478	593	697	937	1,564
Total assets	2,941	3,852	5,736	7,759	8,912
Debt / equity	0.41	0.74	1.20	1.44	0.90

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

520-60659.9

FY22

432-61688.3

FY23

521-753217

FY24

582-1,116543

FY25

511-1,452940

FY26

Operations · YoY (vs a year ago)

—-17%+21%+12%-12%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	520	432	521	582	511
Cash from investing	-606	-616	-753	-1,116	-1,452
Cash from financing	59.9	88.3	217	543	940
Spent on fixed assets	-170	-526	-647	-1,009	-1,428
Free cash flow	350	-93.6	-126	-427	-917
Net cash flow	-26.5	-95.2	-14.7	8.7	-0.6

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

38.8%Mar 24

38.8%Jun 24

38.8%Sep 24

38.8%Dec 24

38.8%Mar 25

34.1%Jun 25

34.1%Sep 25

34.1%Dec 25

34.1%Mar 26

32.5%Jun 26

32.7%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

32.7%promoter

Promoter & group: 32.66%
Public (FIIs, mutual funds, retail…): 67.34%
Promoter change, last quarter: +0.16 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per ShareEx 13-Sep-2024

Board meetings

KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and appr…04-Nov-2026
the financial results for the period ended September 30, 202604-Nov-2026
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2026 to inter-alia consider and appr…03-Aug-2026
the financial results for the period ended Jun 30, 202603-Aug-2026
Fund raising.13-Jun-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates11 Nov
Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates5 Nov
Copy of Newspaper Publication5 Nov
Statement of deviation(s) or variation(s) under Reg. 324 Nov
Statement of deviation(s) or variation(s) under Reg. 324 Nov

Latest news

Krishna Institute of Medical Sciences to host investor meet in Punescanx.trade · 10 Nov, 2:02 pm Buy Krishna Institute of Medical Sciences; target of Rs 885: ICICI SecuritiesMoneycontrol.com · 7 Nov, 4:03 pm Krishna Institute of Medical Sciences Limited Just Missed Earnings - But Analysts Have Updated Their ModelsSimply Wall St · 8 Nov, 8:03 am Krishna Institute of Medical Sciences Ltd Files FY26 PresentationMultibagg AI · 5 Nov, 1:46 am Buy Krishna Institute of Medical Sciences; target of Rs 800: Prabhudas LilladherMoneycontrol.com · 6 Nov, 1:14 pm KIMS Share Price Falls 2.18%: Price Action and AnalysisUnivest · 31 Aug, 12:30 pm KIMS approves merger of zero-turnover hospital subsidiaryMultibagg AI · 5 Nov, 5:32 pm Krishna Institute of Medical Sciences to acquire 51% stake in Insigniascanx.trade · 6 Oct, 12:30 pm

About

About Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited is listed on the NSE under the symbol KIMS and belongs to the Healthcare sector.

Company details

Company name: Krishna Institute of Medical Sciences Limited
NSE symbol: KIMS
BSE scrip code: 543308
ISIN: INE967H01025
Listed on: NSE, BSE, MSEI
Series: EQ (normal equity)
Listed on NSE since: 28 Jun 2021
Face value: ₹2 per share
Market lot: 1 share
Shares issued: 42.00 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Hospital/Nursing Management
Managing director / CEO: Abhinay Bollineni
Chair: Bhaskara Rao Bollineni
Headquarters: Secunderabad, Telangana, India
Registered address: D.NO.1-8-31/1, Minister Road, Secunderabad. Telangana, India - 500003
Founded: 1973
Employees: 18,491
Financial year: April to March
Results basis: Consolidated
Website: kimshospitals.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Krishna Institute of Medical Sciences Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers